Kick–Starting PAT to Achieve Quality by Design in cGMP Bioprocessing
Sponsored by: TechniKrom, Inc.
Length: 19 pages
Content Type: White Paper
Since 2002, the FDA has promoted a continuous, process-centric approach to validation vs. the prior product–centric one. Yet, many pharma and biopharma companies have failed to incorporate that approach into their strategic plan. This white paper explains the new distinctions and what they mean in practice, then identifies PAT opportunities that can be implemented immediately to support QBD activities.
» Download Now

Did you miss the last PharmaManufacturing.com White Paper Alert? View it here.
You can browse more white papers at PharmaManufacturing.com.